Title BCG and COVID-19 : correlation or causality or neither? / Manoj Dayal Chiba (University of Pretoria Gordon Institute of Business Science, Johannesburg, Gauteng, South Africa), Abdullah Verachia (Faculty, University of Pretoria Gordon Institute of Business Science, Johannesburg, South Africa)

Published Bingley, U.K. : Emerald Publishing Limited, 2021 ©2021

Online access available from: Emerald Emerging Markets    View Resource Record

Copies

Description 1 online resource (6 pages) : 10 illustrations Series Emerald emerging markets case studies, 2045-0621 ; volume 11, issue 1 Notes The learning outcome is to understand the difference between correlation and causation The case is set during the period of the COVID-19 pandemic, globally a search for effective treatments were underway. An initial forerunner that was being considered was Bacille Calmette-Guerin (BCG), given its effectiveness in the treatment of tuberculosis and other pulmonary-related infections. While there were a lack of randomised controlled trials, initial data from publicly related secondary data sources indicated that, in countries with BCG inoculation policies, the severity of the spread and mortality of COVID-19 was muted. The case is centered around the available information on BCG and COVID-19 Post-graduate students learning statistics as part of a degree programme. The case assumes no prior statistics knowledge and therefore is aimed at teaching the difference between correlation and causation Teaching Notes are available for educators only Includes index Bibliography Includes bibliographical references Notes Print version record Subject COVID-19 (Disease) -- Treatment -- Statistics -- Case studies BCG vaccines -- Case studies Medical statistics -- Case studies Medical, Infectious Diseases. Epidemiology & medical statistics. Form Electronic book Author Verachia, Abdullah, author

Other Titles Bacille Calmett-Guerin and coronavirus disease 2019

  Permalink